That's life-changing." Ozempic and Mounjaro (used for diabetes), and Wegovy and Zepbound (approved for weight loss), are GLP-1 drugs
It helps regulate glycogen, which impacts energy levels
however, substantial heterogeneity in EPR-mediated accumulation has been reported across tumor types and between preclinical models and human tumors
This study found that the majority of patients stop these drugs within a year, which could be related to how much weight loss they experience, whether they have side effects and how relatively affordable the medications are
The Motley Fool recommends Novo Nordisk, Roche Holding AG, and Viking Therapeutics
Using the 28-day cycle as a guide, if your dose is too low then your cycle would occur every 40 days